Ignite Creation Date:
2025-12-24 @ 7:31 PM
Ignite Modification Date:
2025-12-31 @ 11:22 PM
Study NCT ID:
NCT04488003
Status:
TERMINATED
Last Update Posted:
2024-06-04
First Post:
2020-07-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Ulixertinib for Patients With Advanced Malignancies Harboring MEK or Atypical BRAF Alterations
Sponsor:
BioMed Valley Discoveries, Inc
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
BVD-523-ABC
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None